Home » Health Care

Reimbursement and Health Policy

BIO Principles on Comparative Effectiveness
Milestones in 2006-2007

What happens in Washington influences biotechnology progress every bit as much as what happens on Wall Street or in the lab.

Everywhere You Look Biotechnology Touches Your Life

Has a member of your family been vaccinated against hepatitis B? Do you know someone who has diabetes? Has anyone in your family had heart disease?

Off-Label Use of Anticancer Therapies: Physician Prescribing Trends and the Impact of Payer Coverage Policy

Providers and policy makers must collectively address the profound effect the red-tape hassle can have on the practice of oncology.

Medicare Prescription Drug and Modernization Act of 2003 Fact Sheet

The Medicare conference agreement conforms closely to BIO's principles, and the association urges Congress to act quickly and send the bill to the White House for the president's signature.

Principles on Average Wholesale Price Reforms

Letters, Testimony & Comments

BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter
March 1 2013
  BIO’s comments on the Centers for Medicare and Medicaid Services’ (CMS) draft 2014 Call Letter, submitted Friday,...
Medicaid, Children’s Health Insurance Programs, and Exchanges
February 21 2013
Ms. Marilyn Tavenner, B.S.N., M.H.A. Acting Administrator Centers for Medicare & Medicaid Services Room 445–G, Hubert H....
CED: BIO's Comments in response to the Centers for Medicare and Medicaid Services’ (CMS) Draft Guidance for the Public, Industry, and CMS Staff Coverage with Evidence Development in the context of coverage decision
January 28 2013
Dear Dr. Jacques:            The Biotechnology Industry Organization (BIO) is pleased...
340B: BIO’s Comments to HRSA Regarding the Burden to Conduct 340B Audits
December 21 2012
The Biotechnology Industry Organization (“BIO”) is pleased to submit the following comments in response to “Proposed...
EHB: BIO’s Comments on the Essential Health Benefits Proposed Rule
December 21 2012
          The Biotechnology Industry Organization (BIO) is pleased to submit the following...
More Letters, Testimony & Comments →

Press Releases

BIO Applauds House Committee Vote to Repeal IPAB
March 6 2012
Washington, DC (March 6, 2012) – The Biotechnology Industry Organization (BIO) applauded the House Energy and...
BIO Announces Policy Panel Keynote Session for 2011 BIO International Convention
April 19 2011
WASHINGTON, D.C. (April 19, 2011) - Democratic and Republican party leaders and strategists will share their...
The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
February 9 2011
WASHINGTON, D.C. (Wednesday, February 09, 2011) -The Biotechnology Industry Organization (BIO) today announced that...
Challenges in Reimbursement Hamper Development of Novel Diagnostics
January 6 2011
WASHINGTON, D.C. (Thursday, January 06, 2011) - The Biotechnology Industry Organization (BIO) released today a report...
Media Registration for the 2011 BIO International Convention Now Available Online
January 3 2011
WASHINGTON, D.C. (Monday, January 03, 2011) - The Biotechnology Industry Organization (BIO) announced today that...
More Press Releases →